PL423146A1 - Oleaceina do zastosowanie w prewencji miażdżycy - Google Patents
Oleaceina do zastosowanie w prewencji miażdżycyInfo
- Publication number
- PL423146A1 PL423146A1 PL423146A PL42314617A PL423146A1 PL 423146 A1 PL423146 A1 PL 423146A1 PL 423146 A PL423146 A PL 423146A PL 42314617 A PL42314617 A PL 42314617A PL 423146 A1 PL423146 A1 PL 423146A1
- Authority
- PL
- Poland
- Prior art keywords
- oleacein
- application
- prevention
- intended
- atherosclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Przedmiotem zgłoszenia jest zastosowanie oleaceiny do hamowania procesu tworzenia komórek piankowatych poprzez skuteczne hamowanie wychwytu oxLDL przez makrofagi, zwłaszcza poprzez obniżanie ekspresji makrofagowych receptorów zmiatających. Wywarzane zgodnie z wynalazkiem preparaty farmaceutyczne zawierające oleaceinę nadają się do stosowania w leczeniu lub zapobieganiu miażdżycy, w szczególności w prewencji wczesnych stanów miażdżycowych.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL423146A PL423146A1 (pl) | 2017-10-12 | 2017-10-12 | Oleaceina do zastosowanie w prewencji miażdżycy |
CA3078910A CA3078910A1 (en) | 2017-10-12 | 2018-05-30 | Oleacein for use in atherosclerosis prevention |
CN201880066501.6A CN111212636A (zh) | 2017-10-12 | 2018-05-30 | 橄榄裂环烯醚萜用于动脉粥样硬化预防 |
JP2020541638A JP2020536964A (ja) | 2017-10-12 | 2018-05-30 | アテローム性動脈硬化症予防における使用のためのオレアセイン |
PCT/PL2018/050023 WO2019074383A1 (en) | 2017-10-12 | 2018-05-30 | OLEACEIN FOR USE IN THE PREVENTION OF ATHEROSCLEROSIS |
EP18461563.1A EP3470069A1 (en) | 2017-10-12 | 2018-05-30 | Oleacein for use in atherosclerosis prevention |
US16/755,346 US20200237703A1 (en) | 2017-10-12 | 2018-05-30 | Oleacein for use in atherosclerosis prevention |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL423146A PL423146A1 (pl) | 2017-10-12 | 2017-10-12 | Oleaceina do zastosowanie w prewencji miażdżycy |
Publications (1)
Publication Number | Publication Date |
---|---|
PL423146A1 true PL423146A1 (pl) | 2019-04-23 |
Family
ID=62631043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL423146A PL423146A1 (pl) | 2017-10-12 | 2017-10-12 | Oleaceina do zastosowanie w prewencji miażdżycy |
Country Status (7)
Country | Link |
---|---|
US (1) | US20200237703A1 (pl) |
EP (1) | EP3470069A1 (pl) |
JP (1) | JP2020536964A (pl) |
CN (1) | CN111212636A (pl) |
CA (1) | CA3078910A1 (pl) |
PL (1) | PL423146A1 (pl) |
WO (1) | WO2019074383A1 (pl) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL227843B1 (pl) * | 2012-07-14 | 2018-01-31 | Warszawski Uniwersytet Medyczny | Zastosowanie Ligustrum vulgare L. do wytwarzania preparatu zawierającego oleaceinę |
TWI679985B (zh) * | 2014-10-16 | 2019-12-21 | 日商三得利控股股份有限公司 | 含有橄欖果實萃取物的Tie2活化劑 |
-
2017
- 2017-10-12 PL PL423146A patent/PL423146A1/pl unknown
-
2018
- 2018-05-30 EP EP18461563.1A patent/EP3470069A1/en not_active Withdrawn
- 2018-05-30 CA CA3078910A patent/CA3078910A1/en not_active Abandoned
- 2018-05-30 US US16/755,346 patent/US20200237703A1/en not_active Abandoned
- 2018-05-30 JP JP2020541638A patent/JP2020536964A/ja active Pending
- 2018-05-30 WO PCT/PL2018/050023 patent/WO2019074383A1/en active Application Filing
- 2018-05-30 CN CN201880066501.6A patent/CN111212636A/zh active Pending
Non-Patent Citations (2)
Title |
---|
KISS AK, MAŃK M, MELZIG MF, DUAL INHIBITION OF METALLOPEPTIDASES ACE AND NEP BY EXTRACTS, AND IRIDOIDS FROM LIGUSTRUM VULGARE L, 2008 * |
NARUSZEWICZ M, CZERWIŃSKA ME, KISS AK, OLEACEIN. TRANSLATION FROM MEDITERRANEAN DIET TO POTENTIAL ANTIATHEROSCLEROTIC DRUG, 2015 * |
Also Published As
Publication number | Publication date |
---|---|
WO2019074383A1 (en) | 2019-04-18 |
CA3078910A1 (en) | 2019-04-18 |
CN111212636A (zh) | 2020-05-29 |
EP3470069A1 (en) | 2019-04-17 |
US20200237703A1 (en) | 2020-07-30 |
JP2020536964A (ja) | 2020-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018236800B2 (en) | DNA-PK inhibitors | |
PH12018502125A1 (en) | Bipyrazole derivatives as jak inhibitors | |
PH12017502051A1 (en) | TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF | |
TN2017000009A1 (en) | Spirocycloheptanes as inhibitors of rock. | |
MX2018008052A (es) | Inhibidores de desmetilasa especifica de lisina 1 (lsd1). | |
TN2017000544A1 (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as magl inhibitors | |
TN2017000483A1 (en) | Triazole agonists of the apj receptor. | |
UA113440C2 (xx) | Сполуки тетрагідропіразолопіримідину | |
MX338489B (es) | Derivados de hidantoina utiles como inhibidores de kv3. | |
PH12017501095A1 (en) | Piperidine derivatives as hdac1/2 inhibitors | |
PH12017500836A1 (en) | Transdermal formulations | |
EA202090183A1 (ru) | Композиции, способы и получение дейтерированного домперидона | |
MX2018004664A (es) | Antagonistas de ep4. | |
MX2016003823A (es) | Inhibidor selectivo de fosfatidil-inositol 3-cinasa-gamma. | |
MX2018006700A (es) | Inhibidores aza-bencimidazol de peptidilarginina desiminasa (pad4). | |
MA40583A (fr) | Nouveaux activateurs de la guanylate cyclase soluble et leur utilisation | |
MX2017016619A (es) | Derivados de pirimidina como inhibidores de tirosina cinasa de bruton (btk) y usos de los mismos. | |
MX2016006975A (es) | Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias. | |
MA39824A (fr) | Composés azole amido-substitués | |
TR201902741T4 (tr) | Kişisel Temizlik Bileşimleri | |
MX368496B (es) | Análogos de compuestos de 4h-pirazolo[1,5-a]bencimidazol como inhibidores parp. | |
DOP2015000176A (es) | Compuestos de azetidiniloxifenilpirrolidina | |
IN2014CN03625A (pl) | ||
MX2015013740A (es) | Derivados de pirazolnaftridinona, preparacion y uso terapautico de los mismos. | |
PL423146A1 (pl) | Oleaceina do zastosowanie w prewencji miażdżycy |